Violence in Psychiatry

Table of Contents

List of contributors
Part I. Statement of the Problem:
1. Deinstitutionalization and the rise of violence
2. The new mission of forensic mental health systems: managing violence as a medical syndrome in an environment that balances treatment and safety
Part II. Assessment:
3. The evolution of violence risk assessment
4. Assessment of aggression in inpatient settings
5. Clinical assessment of psychotic and mood disorder symptoms for risk of future violence
6. Inpatient aggression in community hospitals
7. Prevalence of physical violence in a forensic psychiatric hospital system during 2011–2013: patient assaults, staff assaults, and repeatedly violent patients
8. The psychiatrist's duty to protect
Part III. Neurobiology:
9. Deconstructing violence as a medical syndrome: mapping psychotic, impulsive, and predatory subtypes to malfunctioning brain circuits
10. Aggression, DRD1 polymorphism, and lesion location in penetrating traumatic brain injury
11. Is impulsive violence an addiction? The habit hypothesis
12. The neurobiology of psychopathy: recent developments and new directions in research and treatment
13. The neurobiology of violence
14. Impulsivity and aggression in schizophrenia: a neural circuitry perspective with implications for treatment
15. Serotonin and impulsive aggression
Part IV. Guidelines:
16. California State-Hospital Violence Assessment and Treatment (Cal-VAT) guidelines
Part V. Psychopharmacology:
17. Effectiveness of antipsychotic drugs against hostility in patients with schizophrenia in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study
18. Clozapine: an effective treatment for seriously violent and psychotic men with antisocial personality disorder in a UK high-security hospital
19. Augmentation of clozapine with amisulpride: an effective therapeutic strategy for violent treatment-resistant schizophrenia patients in a UK high-security hospital
20. The psychopharmacology of violence: making sensible decisions
21. Treating the violent patient with psychosis or impulsivity utilizing antipsychotic polypharmacy and high-dose monotherapy
22. A rational approach to employing high plasma levels of antipsychotics for violence associated with schizophrenia: case vignettes
23. Illustrative cases to support Cal-VAT guidelines
Part VI. Treatment Interventions:
24. A new standard of care for forensic mental health: prioritizing forensic intervention
25. Forensic focused treatment planning: a new standard for forensic mental health systems
26. Implementing an ecological approach to violence reduction at a forensic psychiatric hospital: approaches and lessons learned
27. The appropriateness of treating psychopathic disorders
28. Psychosocial approaches to violence and aggression: contextually anchored and trauma-informed interventions
29. Co-morbid mental illness and criminalness: implications for housing and treatment
30. Crime, violence and behavioral health: collaborative community strategies for risk mitigation
31. New technologies in the management of risk and violence in forensic settings
32. Risk reduction treatment of psychopathy and applications to mentally disordered offenders
Index.

• Editors

  Katherine D. Warburton, University of California, Davis
  Katherine D. Warburton is the Medical Director and Deputy Director for Clinical Operations for the California Department of State Hospitals and Assistant Professor of Clinical Psychiatry at the University of California, Davis. She is the guest editor of a special issue on violence for CNS Spectrums with Dr Charles Scott and an expert in violence risk assessment and treatment of violence, and applying medical evidence to policy in a state hospital system.

  Stephen M. Stahl, University of California, San Diego
  Stephen M. Stahl is Adjunct Professor of Psychiatry at the University of California, San Diego and Honorary Visiting Senior Fellow at the University of Cambridge. He is the author of the market leading textbook Stahl's Essential Psychopharmacology, as well as more than five hundred other articles and chapters. Dr Stahl is an internationally recognized clinician, researcher and teacher in psychiatry and psychopharmacology.

  Contributors

  E. Fuller Torrey, Katherine D. Warburton, John Monahan, Jennifer L. Skeem, Barbara E. McDermott, Brian J. Holoyda, Charles L. Scott, Phillip J. Resnick, Katalin A. Szabo, Christopher L. White, Stephen E. Cummings, Raziya S. Wang, Cameron D. Quanbeck, Charles Broderick, Allen Azizian, Rebecca Kornbluh, James Knoll, Stephen M. Stahl, Matteo Pardini, Frank Krueger, Colin A. Hodgkinson, Vanessa Raymont, Maren Strenziok, Mario Amore, Eric M. Wassermann, David Goldman, Jordan H. Grafman, Michael A. Cummings, Larry J. Siever, Dan Rosell, Matthew J. Hoptman, Emil F. Coccaro, Jennifer Fanning, K. Luan Phan, Royce Lee, Debbi A. Morrissette, Shannon Bader, Laura Dardashti, Darci Delgado, Jonathan Meyer, Jennifer O'Day, George Proctor, Benjamin Rose, Marie Schur, Eric Schwartz, Susan Velasquez, Jan Volavky, Pál Czobor, Leslie Citrome, Richard A. Van Dorn, Darcy Brown, Fintan Larkin, Samrat Sengupta, Jose L. Romero-Ureclay, Callum C. Ross, Nitin Gupta, Morris Vinestock, Mrigendra Das, James E. Hotham, Patrick J. D. Simpson, Rosalie S. Brooman-White, Amlan Basu, Sharon A. Humphreys, Jan Volavka, Robert Schaufenbil, Sean E. Evans, Alan R. Felthous, Deborah Horowitz, Margaret Guyer, Kathy Sanders, Robert D. Morgan, Nicole R. Bartholomew, Debra A. Pinals, John Tully, Thomas Fahy, Stephen Wong, Mark Olver